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Abstract 
Advances in genomic technologies and the promise of “personalised medicine” have 
spurred the interest of researchers, healthcare systems, and the general public. 
However, the success of population-based genetic studies depends on the willingness 
of large numbers of individuals and diverse communities to grant researchers access 
to detailed medical and genetic information. Certain features of this kind of research – 
such as the establishment of biobanks and prospective data collection from 
participants’ electronic medical records – make the potential risks and benefits to 
participants difficult to specify in advance. Therefore, community input into biobank 
processes is essential. In this report, we describe community engagement efforts 
undertaken by six United States biobanks, various outcomes from these engagements, 
and lessons learned. Our aim is to provide useful insights and potential strategies for 
the various disciplines that work with communities involved in biobank-based 
genomic research.  
Introduction 
Since the completion of the Human Genome Project in 2003, advances in technology 
have allowed for rapid sequencing, storage, and analysis of human DNA. These 
developments have led to unprecedented interest and investment in genomic research, 
with the ultimate goal of improving public health.2 This interest has been fuelled, in 
large part, by the vision of “personalised medicine,” in which prevention and 
treatment would be tailored to individuals’ unique genomic risks and 
predispositions.3,4,5 Genome-wide association studies and similar epidemiological 
research approaches are laying the foundation for personalised medicine, and the 
success of these strategies depends on the willingness of large numbers of individuals 
and diverse communities to grant access to detailed medical and genetic information. 
To facilitate this kind of research, biobanks (defined as repositories of human DNA, 
RNA, tissue, blood, cells, and health data) are being established around the world, at 
both local and national levels.6,7 Many of these biobanks are beginning to link data 
from study participants’ electronic medical records (EMRs) with their genetic data to 
accelerate the study of genotype-phenotype associations. 
  
While EMR-linked biobanks promise to be a powerful research tool, they raise 
important social and ethical issues for individuals and communities. One issue is the 
security of an individual’s private, personal information. Recent studies have shown 
that de-identification of research data and tissue samples may fail to provide adequate 
participant security.8,9 In addition to risks from possible re-identification, other key 
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issues for consideration include how to engage participants appropriately in the 
consent process with respect to undefined future research using their samples and 
data;10 how or whether to return research results11 and unanticipated findings to 
participants;12 and how to protect the interests of the communities involved in the 
research.13  
 
Recent, highly publicised controversies – including the settlement between Arizona 
State University and the Havasupai tribe over the use of stored blood samples14,15 and 
the research use of blood spots from newborns in Texas without parental consent16 – 
have highlighted the harms that research participants and investigators may encounter 
in the context of genetic research using banked samples and data. In both of these 
examples, researchers sought to make use of available biospecimens to further 
scientific aims, and in both cases, research participants or their family members 
objected when they learned how the samples were being used. From an ethical 
standpoint, community engagement offers an opportunity to show respect for the 
individuals and communities involved in research and it may also be instrumental in 
preventing barriers to future research. 
Community engagement 
It is important to understand the concept of “community” in developing appropriate 
engagement strategies. “Community” can have many different meanings. For this 
paper, community refers to the variety of stakeholders affected by, or interested in, 
biobanking and genetic research issues. Similarly, the term “community engagement” 
has a number of connotations. Community engagement (CE) – “a process of inclusive 
participation that supports mutual respect of values, strategies, and actions for 
authentic partnership of people affiliated with or self-identified by geographic 
proximity, special interest, or similar situations to address issues affecting the well-
being of the community of focus”17 – has been proposed as an important step in 
ensuring that biobank research is carried out in an ethical, locally appropriate manner. 
CE can include a spectrum of community involvement and can be used to inform, 
consult, involve, collaborate with or empower communities.18,19  
  
Institutions and groups worldwide have recognised the value and benefits of 
community engagement in health prevention, research and policy initiatives. A report 
from the Bellagio Group, an international expert committee convened in 2005, named 
communication and stakeholder engagement as a core activity ultimately to improve 
population health through informing, and thus empowering, the public about uses of 
genomic information in disease prevention.20 The National Institutes of Health (NIH) 
Office of Science Policy has likewise determined that CE can enhance research 
quality, improve protection of participants, and address local public health needs.21 
Recognising the importance of community input in clinical research, the 60 US 
medical research institutions receiving NIH-funded Clinical and Translational Science 
Awards are required to include a community engagement component.22 Perhaps most 
relevant to biobank efforts, CE activities can help establish mutual understanding and 
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trust among stakeholders with disparate interests: research participants, the general 
public, investigators, research and healthcare institutions, and funders.23,24 
 
Despite the widespread endorsement of CE efforts and a growing literature reporting 
the results of such projects involving large-scale genomic databases and biobanks in 
various countries,25,26,27,28,29 there is a lack of information describing how engagement 
activities may be tailored to unique biobank contexts and communities; the role of 
empirical research studies versus more operationally oriented approaches (eg 
community advisory boards); and the impact these efforts can have on biobank policy 
and practice. In this report we describe community engagement efforts undertaken by 
six United States biobanks involved with the eMERGE Network, various outcomes 
from these engagements, and lessons learned. Our aim is to provide useful insights 
from these efforts and potential strategies for the multiple disciplines that work with 
communities involved in biobank-based genomic research.  
Community engagement strategies within the eMERGE Network  
The eMERGE Network is a consortium of US research institutions funded by the 
National Human Genome Research Institute (NHGRI) to develop, disseminate, and 
apply approaches to combining genomic and EMR data for genetic research.30 The 
consortium also includes a focus on ethical, legal and social issues (ELSI) in 
biobanking, utilising monthly teleconferences to discuss specific issues such as data 
sharing, return of research results, participant consent issues, and the role of 
community engagement.31 Quarterly in-person meetings provide updates on genetic 
research progress and highlight group efforts to address ELSI and CE strategies. 
eMERGE I Network members include Group Health Cooperative/University of 
Washington (GHC/UW), Marshfield Clinic, Mayo Clinic, Northwestern University, 
and Vanderbilt University. Kaiser Permanente (KP) is affiliated with the eMERGE 
Network for the purposes of discussing ethical and regulatory issues. Table 1 presents 
an overview of the six biobanks’ characteristics, and Table 2 provides a summary of 
community engagement efforts. 
  
The community engagement efforts conducted by the sites involved with eMERGE 
were neither designed nor intended to be coordinated. Instead, each was a local 
response to the NHGRI funding requirement. The following section highlights one CE 
activity from each site to demonstrate the range of possible approaches and to 
illustrate how the biobanks tailored their CE activities to: (1) the specific stakeholders 
or community; (2) the context of the biobank (eg from an existing disease-specific 
study, or from a general biobank; opt-in vs. opt-out model); and (3) the stage of the 
biobank development. Outcomes presented are broad and include process and impact 
components. All CE empirical studies were approved by the individual site’s 
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Group Health Cooperative/University of Washington 
Background 
Group Health Cooperative is a consumer-governed, nonprofit health organisation that 
provides medical care and health insurance to more than 580,000 members in the 
Pacific Northwest and Northern Idaho. Headquartered in Seattle, the Cooperative is 
part of a regional culture that values citizen participation in civic decision-making. Its 
members are primarily white, middle class, and relatively well-educated.  
 
For the eMERGE project, the Group Health Research Institute has partnered with 
researchers at the University of Washington and the Fred Hutchinson Cancer 
Research Center to investigate genotype-phenotype links for dementia, carotid artery 
atherosclerotic disease, and statin-use complications. The project uses genetic and 
health data from the Adult Changes in Thought (ACT) Study,32 a longitudinal study 
begun in 1994 that focuses on age-related dementia and cognitive decline. Participants 
are randomly selected Group Health members age 65 and older who were free of 
dementia at study entry. Although the original ACT consent covered genetic analysis, 
access to medical record data, and the possibility of data sharing with researchers 
outside Group Health, the Group Health IRB determined that the deposition of study 
data in the NIH database of Genotypes and Phenotypes (dbGaP) warranted re-consent. 
The re-consent process is described elsewhere.33 
 
CE Method Highlighted 
Negotiations with the Group Health IRB about re-consent for eMERGE participation 
highlighted the need for internal policy to govern the conduct of large-scale genomic 
research, as well as the need for empirical data about members’ preferences, goals, 
and concerns. The GHC/UW community engagement project began with a focus 
group study34 to gather member perspectives about participation in genome-wide 
association studies linking genetic data and EMR data and continued with a consensus 
development panel of stakeholders. The consensus development panel (CDP) is 
presented here. The CDP had three goals: (1) to discuss genome-wide association 
studies (GWAS) and related whole-genome research and the ethical, legal, and social 
implications of such studies; (2) to develop recommendations for Group Health 
leadership for policy on GWAS and similar work; and (3) to serve as a demonstration 
project for similar efforts across the United States. The group consisted of 13 
members representing GH members, researchers, healthcare providers, and legal and 
administrative representatives. The panel met in person seven times to deliberate on 
issues it identified as key priorities, including informed consent, return of research 
findings to participants, and sharing study data with researchers outside GH.  
 
Outcomes 
The consensus panel arrived at 11 key recommendations, outlining the ways in which 
research risks should be described to prospective participants; the advisability of re-
consent; the need to offer aggregate – and where appropriate, individual – research 
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findings to participants; and the clear description of datasharing plans as part of the 
informed consent process. The panel also urged GH to ensure that genetic studies are 
reviewed and managed in the same fashion as other kinds of research, while 
acknowledging public perceptions that genetic research can be more risky than other 
forms of health research. These recommendations formed the basis of a final report 
presented to the Group Health Cooperative Board of Trustees in December 2009. A 
manuscript is in preparation. 
Kaiser Permanente 
Background 
The Kaiser Permanente (KP) Research Program on Genes, Environment, and Health 
(RPGEH) is building a population-based biobank that integrates clinical data from 
electronic medical records, biospecimens, and information on behavioral and 
environmental factors.35 The programme seeks participation from 500,000 adult KP 
health plan members in Northern California. When completed it will represent one of 
the largest and most diverse biobanks in the US. KP members 18 years and older are 
eligible to participate and are recruited via a mailed invitation letter in English, 
Spanish or Chinese. Participants give broad consent for their data and biospecimens to 
be used for research. Some 430,000 members have contributed survey data, 160,000 
of whom have also contributed a biospecimen. 
  
CE Method Highlighted 
The objectives of the RPGEH’s community engagement efforts are both content- and 
process-oriented: to obtain community consultation and to build a relationship that 
values the community’s role in biobank research. The community engagement process 
has used surveys, focus groups, interviews and a Community Advisory Panel (CAP) 
in order to gain the perspectives of various stakeholders. The CAP (highlighted here) 
provides an opportunity to develop and strengthen an ongoing relationship between 
multiple community representatives and the RPGEH. There have been two cohorts of 
CAP members since 2006, each lasting two years and including about 25 members. A 
third CAP is currently being recruited. Engagement involves participation in quarterly 
meetings, ongoing dialogue and consultation about various RPGEH related activities, 
and participation in other advisory and working groups. CAP members receive an 
honorarium of $100 for each meeting attended. 
  
CAP membership reflects a diversity of sociocultural communities, including: KP 
members, local residents, patient advocates, genetics experts, representatives of 
historically under-represented communities, safety net and public health providers, 
local government, faith-based organisations, and corporate health plan purchasers. 
CAP members are leaders or individuals who represent a certain constituency or 
provide important expertise.  
  
The process of building a relationship of mutual learning and trust between the 
RPGEH and CAP members, in which community members and researchers feel 
© ESRC Genomics Network.
18         Genomics, Society and Policy 
             2010/11, Vol.6, No.3 pp.50-67 
 
 
_____________    
 





comfortable asking each other questions, uses a variety of community organizing and 
capacity building methods and a mix of small-and large-group activities. RPGEH and 
community members plan meetings together to encourage more equitable power 
dynamics. Similarly, meeting agendas attempt to reflect the joint priorities of CAP 
and RPGEH leaders. 
  
Outcome(s) 
 The CAP has assisted in reviewing research processes, protocols, and instruments, 
and provided feedback on reasons for, and barriers to, participation in the RPGEH. It 
has also provided input on the range of community concerns about genetics research. 
The CAP has proven to be a successful mechanism to help create a stronger 
relationship between researchers and community members and has been instrumental 
in providing guidance on a number of issues. One noteworthy example is their input 
on the importance of obtaining participants’ reconsent before depositing their data in 
dbGaP. Their recommendation that the RPGEH use an opt-in mechanism for re-




The Personalized Medicine Research Project (PMRP) is a large population-based 
biobank enrolling people from Central Wisconsin who receive their medical care at 
Marshfield Clinic.36,37 Currently there are approximately 20,000 enrolled and 
recruitment is ongoing. The database includes DNA, plasma, serum samples, and 
questionnaire data. Medical records can be accessed for additional information 
relevant to outcomes being studied. The biobank was developed to help facilitate 
genomics research and community engagement is ongoing. 
 
The community engagement process for PMRP has involved three main activities: 
focus groups, the organisation of a Community Advisory Group (CAG), and public 
education/community communication. Efforts to engage the community started prior 
to the beginning of enrolment into PMRP and continue throughout the recruitment 
and enrolment process. Details of the complete PMRP community engagement 
process are published elsewhere.38 
 
CE Method Highlighted  
In this paper, the focus will be on methods used for public education and community 
communication that were targeted at adults (18 years of age and older) in Central 
Wisconsin. The goal was to increase knowledge and understanding about PMRP prior 
to beginning biobank participant enrolment. Community groups such as Rotary, 
Lions, and Kiwanis were provided with names of speakers to talk about PMRP at their 
meetings. The CAG helped to identify additional groups and organisations to be 
contacted. Talks to community organisations were heard by approximately 1,000 
potentially eligible participants, timed with recruitment in that area. There was a video 
that could be used at these talks, and a brochure, a flyer, a poster and a ‘frequently 
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asked questions’ (FAQ) pamphlet were developed and used in letters of invitation, as 
handouts at community talks, and for placement throughout the Marshfield Clinic. 
Local and national media releases were sent out to coincide with the launch of 
enrolment. Local media releases announced the 1,000th, 5000th, 10,000th and 15,000th 
participant enrolments, and media releases announced the start of the first two studies 
utilising PMRP data. Newsletters are sent out periodically to inform PMRP 
participants of current studies, findings, and developing issues related to PMRP and 
are available for recruiting, community interest, and education. A website was 
developed that includes information about PMRP, detailed programmatic materials, 




A number of lessons were learned from this engagement process. The initial education 
materials were far too dense. With input from focus groups and the CAG, the longer 
documents were shortened and simplified, leading to more meaningful and usable 
education tools. Adding a tear-off packet that listed the project name and contact 
information to the poster was effective and convenient. The video was not worth the 
expense because it became out of date quickly and it was often challenging to use it in 
local venues when speaking to a community group. Being aware of unique subgroups 
within the community, i.e. medical, service and civic organisations, allowed for 
development of appropriate means of disseminating information. Strategies and 




The Mayo Clinic Biobank is a multi-purpose population-based biobank of Mayo 
Clinic patients.39 The Mayo Clinic has locations in Minnesota, Florida, and Arizona. 
The population is not geographically constrained – there are patients who travel to the 
Mayo Clinic from all over the world who may participate in the biobank. The biobank 
is located in Rochester, Minnesota. All Mayo Clinic patients aged 18 and older, who 
are legal residents of the US, are eligible for participation. Participants are recruited 
during routine medical appointments. Unsolicited volunteers are also accepted. As of 
December 2010 more than 14,000 individuals had consented to participate, with 
recruitment ongoing. In addition to providing blood samples, participants complete a 
health questionnaire and authorise access to clinical data and other tissue collected in 
the course of treatment.  
 
Mayo Clinic has conducted a number of community engagement efforts. The first 
engagement was a deliberative democracy event held to facilitate community 
influence in the development and governance of the biobank. Other engagements have 
included an interview study of Mayo patients and a survey of Olmsted County, 
Minnesota, USA, residents to learn more about the community’s opinions on the 
biobank.  
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CE Method Highlighted 
In September 2007, the Mayo Clinic held a deliberative democracy event to engage 
community members. The goal of the event was not only to allow the expression of 
different points of view, but to also encourage real compromises and the formulation 
of new policy recommendations for the Mayo Biobank. Additional aims were to learn 
the opinions of community members about biobanks generally, and to evaluate new 
methods for community engagement in biobanking. 
 
All participants in the deliberative democracy event were residents of the county in 
which the Mayo Clinic is situated, and were sampled to represent the county’s 
demographic composition. Members of minority groups in the community were over-
sampled to ensure representation in the deliberations. The number of participants was 
small and the racial/ethnic profile of the county is relatively homogenous, so 
specifically selecting for minorities was necessary. The Rochester Epidemiology 
Project (REP) provided both local demographic information and lists of potential 
participants.40 Thirty potential participants were recruited, and 21 participated in the 
event. Participants were paid $400 for their time and effort.  
 
Prior to the event, each participant was sent a booklet describing DNA biobanking 
that included an explanation of the science involved, the aims of biobank-based 
research, and an introduction to common ethical concerns. On day one, professional 
stakeholders gave presentations outlining the promises and challenges of biobanking 
from various viewpoints, including those of researchers, patient advocates, legal 
professionals, and privacy specialists. On days two and three, participants were 
divided into three small groups to facilitate open discussion. Professional facilitators 
led the small-group discussions. On day two, the groups explored individual values, 
hopes, and concerns. On day three, they developed specific recommendations. During 
the afternoon of day four, everyone reconvened in the large group and discussed the 
various recommendations. The entire engagement was recorded, and the recordings 
were transcribed and analysed.  
 
Outcome(s) 
Specific policy recommendations produced by the community engagement event that 
have been implemented in the design and operation of the Mayo Biobank include: 1) 
development and use of a simplified informed consent process; 2) an option for 
participants to withdraw from the biobank; 3) ongoing community oversight, 
including the creation of a Community Advisory Board; and 4) publication of a 
community newsletter and website to inform participants and community members 
about the biobank. 
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The Northwestern University biobank, NUgene, is a biospecimen repository with 
longitudinal medical information from an ethnically diverse urban population of 
patients at Northwestern University-affiliated hospitals and outpatient clinics.41 Since 
2001, more than 10,000 Chicago area patients have enrolled in NUgene. Participants’ 
biospecimens are combined with data from a questionnaire and updates from EMRs. 
Patients are recruited through a variety of clinical settings, and consent to the 
distribution and use of de-identified samples and data for genetic research. 
  
The eMERGE community engagement process involved a mixed-methods approach 
utilising focus groups, a national survey of Institutional Review Board (IRB) 
professionals,42 and a consensus meeting to obtain input from various community 
stakeholders regarding the consent process for high-throughput genomic research and 
sharing of genetic research data. The first phase of this process will be presented here. 
  
CE Method Highlighted 
The goal of the first CE phase was to gather information about biorepository 
participants and the public’s views toward genetic research and data sharing. Focus 
groups were chosen as a less structured method of eliciting data, one which allowed 
for open discussion, varying viewpoints, discovery of unanticipated findings, and 
clarification of information. Eligible biorepository study participants were NUgene 
participants, 18 years or older, not previously contacted for other research studies, and 
English speaking. Eligible public participants were 18 years or older and English 
speaking. They were recruited from three diverse Chicago neighborhoods 
representing the geographic areas from which the NUgene Project recruits 
participants. 
  
To help facilitate discussion, participants received a one-page fact sheet that the 
investigators developed and pretested, summarising the NIH Data Sharing Policy43. A 
brief information form, completed by each focus group participant, included standard 
demographic measures and two questions about medical information and research. 
Three NUgene participant focus groups (n=21) were conducted at Northwestern 
University’s Chicago campus, and three public focus groups (n=28) were conducted 
at three Chicago neighborhood facilities in May, 2008. Participants received a $70 gift 
certificate and their travel was reimbursed. 
  
Experienced moderators used a pretested focus group discussion guide consisting of 
eight open-ended questions directly relating to the study’s objectives. Focus group 
discussions were audiotaped and transcribed and independent checks by two 
investigators confirmed accurate and verbatim transcription. Data reduction and 
analysis were conducted through standard qualitative methods of coding, notation, 
and theme identification. Detailed findings are reported elsewhere.44 
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Data from the focus group and survey studies were presented at a consensus meeting 
of diverse stakeholders such as clinicians, investigators, ethicists, regulatory 
professionals and patient advocates, held in December 2009 at Northwestern 
University. These engagement efforts identified participant views about data sharing, 
influenced biobank patient communication, and informed written consent materials 
and mechanisms used to educate biobank participants. In particular, focus group 
participants expressed an interest in receiving further information about genetic 




Vanderbilt’s biobank, BioVU, is composed of a synthetic derivative (SD) of 
Vanderbilt University Medical Center’s (VUMC) electronic medical record and DNA 
extracted from residual blood samples collected in the course of clinical care in the 
outpatient setting and scheduled to be discarded.45,46 The SD contains all clinical 
information in the EMR and its associated entry-order relational database but stripped 
of personal identifiers and modified in other ways. The name ‘synthetic derivative’ 
comes from both alterations (eg date shifting to mask actual dates, which protects 
against re-identification) and extractions (eg of textual and structured information that 
is identifiable). Although BioVU data is considered by the Vanderbilt IRB to be of 
non-human origin, patients are given the opportunity to opt out of having DNA 
included in this repository.47 DNA has been collected from samples from adults since 
2007, and from children since 2009. Access to the SD and BioVU is subject to 
oversight primarily by the IRB and an internal, multi-disciplinary Operations 
Oversight Board.  
  
Because of the unique nature of this approach, a variety of efforts have been made 
since the conceptualisation stage of BioVU to engage and respond to the various 
communities who may be involved in BioVU. Patients were originally surveyed about 
their attitudes and preferences,48 and are routinely surveyed about their understanding 
about the opt-out process;49 faculty and staff participated in a web-based survey; and 
two focus groups and a large survey were conducted with community members. 
BioVU has a community advisory board composed of a diverse group of individuals 
who make recommendations about emerging issues. The community engagement 
effort involving patient exit interviews (PEI) will be presented in this paper. 
  
CE Method Highlighted 
Since BioVU is based on a non-human subjects model, with biological samples 
collected from residual clinical samples, individuals do formally give consent for 
inclusion in the biobank. Patients are notified of BioVu in their standard Consent to 
Treatment/Agreement to Pay forms and processes at the time of registration. For this 
reason, exit interviews conducted at the time patients are interacting with the 
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registration process are an integral component of the development and ongoing 
operation of the BioVU resource. This approach has been employed routinely since 
2006 to assess: the effectiveness of posters and informational bulletins in 
communicating the existence of the programme to patients; the awareness of the 
BioVU programme among adult patients in outpatient clinics; and the acceptability of 
the BioVU model among parents in preparation for a paediatric expansion. Adult 
patients were interviewed at the time of their exit from the phlebotomy area, and the 
parents of paediatric patients were interviewed at the time of their child’s subspecialty 
or primary care clinic visit. Interviews included brief surveys with both structured and 
open-ended questions. In all cases, interviews were kept brief. Participation rates have 
been high (70 per cent or greater of parents/patients approached in any given study 
have agreed to be interviewed). The times, days, and locations varied in each effort to 
ensure a random sample of patients was obtained.  
  
Outcome(s) 
The information gathered through these efforts has informed biobank programme 
development and implementation, altered the set of communication materials, and 
guided the paediatric expansion. Because of the helpfulness of these approaches, 
information from exit interviews has become a critical continuing component of 
programme evolution and evaluation. 
Discussion  
An increasing number of biobanks are being developed to collect and store DNA and 
other health data from large numbers of individuals. Demonstrating respect for 
persons who volunteer to participate in research is an ethical good in itself. Moreover, 
by taking the initiative to engage their respective communities, researchers lay the 
groundwork to foster mutual understanding and trust,50 encourage public interest and 
participation in research, and potentially enhance the impact of their studies. Ongoing 
communication and relationships with research participants are also important. When 
questions or concerns do arise about participant data, such relationships may help to 
avoid outcomes such as a ban on research, as in the Havasupai case,51,52 or destruction 
of samples, as in the Texas blood spot settlement.53 Furthermore, engaging with 
communities can provide empirical data to aid policy-makers, genomic researchers, 
public health scientists, and community leaders in developing locally appropriate 
policies and procedures for biobank-based research.  
 
Community engagement represents an important means of balancing pragmatic 
concerns (such as resource limitations and regulatory requirements) with ethical 
norms. In many cases, funding agencies now mandate an ethics component in large-
scale genomic research applications. Furthermore, investigators’ plans should take 
into account not only the research goals but also the unique characteristics of the local 
community. These interests and motivations should shape the goals, as well as the 
method of community engagement adopted by the biobank. As a result, community 
engagement will require diverse approaches.  
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Although community input did lead to improvements in biobanking procedures and 
protocols, a number of challenges were also encountered. For example, eliciting 
participant views about biobanking and research was sometimes difficult as not all 
participants were familiar with genomics and informatics. To address this issue, some 
of the sites offered pre-reading materials, educational presentations with time for 
questions and answers, and supplementary website information. Some sites also had 
challenges in recruiting diverse participants and eliciting multiple perspectives. To be 
more inclusive, plans included oversampling of minorities for engagement efforts and 
actively recruiting participants who were supportive, as well as cautious, to participate 
in biobank efforts.  
  
Likewise, a number of sites had some difficulties in identifying diverse and active 
participants for their community advisory groups. To ensure diversity of their 
community advisory members, sites worked closely with community leaders and 
consulted with community academic partners to identify a broad representation for 
their advisory boards. To encourage participation over time, sites offered 
compensation and involved the community advisory members in the agenda-setting 
and meeting facilitation process. Some of the advisory groups had trouble coming to 
consensus on issues discussed, which presented the challenge of incorporating 
differing views into recommendations. To facilitate consensus, one site allowed for as 
many meetings as were necessary for discussion, brought in external speakers, and 
held joint meetings of their expert and community advisory groups.  
  
Lastly, an overarching constraint, similar to that of other community engagements, is 
the level of resource commitment needed. CE can require a considerable time 
commitment, increased costs, and specialised expertise.54,55,56 One strategy to increase 
available resources was to include the costs of newsletters and meetings of 
community advisors as necessary expenses in grant applications. eMERGE ELSI 
investigators also shared their experiences and expertise with one another and helped 
review tools and CE protocols in development stages, providing valuable insight. The 
experience of the eMERGE partners demonstrates that one size of community 
engagement does not fit all, and that an up-front investment of time and resources is 
important for engagement efforts to succeed.  
Future directions and research 
The eMERGE Network biobank sites plan to explore the impact and evaluation of 
CE, and to continue community engagements via newsletters, community advisory 
boards, and empirical data gathering. Additional discussions are planned for 
investigators throughout the eMERGE Network to share and receive feedback on their 
biobanking and CE experiences, challenges, and future opportunities.  
  
To further our understanding about how best to conduct and utilise CE efforts in the 
context of biobanking and large-scale genomic research, future research is needed to 
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provide systematic evaluation of the effectiveness of various methods of community 
engagement and to assess the impact these research institution–community 
partnerships have on research processes, outcomes, practice, and policy. Although a 
number of organisations have set out general principles, frameworks, and best practice 
for successful community engagements,57,58,59, currently no standardised measures 
exist for evaluating CE goals and outcomes in biobank-based research. 
 
In addition, further efforts are needed to identify ways to translate the findings of 
biobank-based community engagement efforts into institutional and broader health 
policy developments. How should empirical data from community engagements be 
incorporated into policy? How can the informational needs of policymakers be 
incorporated into the design of community engagement activities? How should 
policymakers weigh community views when there are important differences among 
stakeholders’ perspectives?  
Conclusion 
As population-based biobank research activities continue to increase, so does the need 
for input from stakeholders and community members in the development of 
appropriate institutional practices and broader public policy. Increasingly, funding 
agencies require that proposed research include a community engagement component, 
in recognition that such efforts can improve the quality and impact of biobank-based 
research. Biobank CE efforts need to have clearly defined goals; they should tailor 
approaches to the local context, and create processes to support continued interaction 
between research institutions and the community. The varied eMERGE Network 
community engagement experiences reported here are presented with the hope that 
they will provide useful insight and information for other communities and 
investigators planning, or already conducting, biobank-based research efforts.  
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